Copaxone first on FDA’s list for faster complex generic approvals
Teva will attempt to block generic launch in courts
Teva will attempt to block generic launch in courts
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
Unlike AZ’s Soriot, Schultz “couldn’t refuse” top job at Teva.
Allergan generics buyout left Teva with $35m debts
Breast cancer blockbuster facing potential trio of US competitors.
Discount swings NICE decision, drug will compete with GSK rival
Teva accused of “pay for delay” deal with Cephalon.
Soriot to host results announcement as usual